Phacilitate Talks Episode 1 The impact of Covid-19 and Future Pandemics on Getting Advanced Therapies to Patients

Episode 1: the impact of Covid-19 and Future Pandemics on Getting Advanced Therapies to Patients

Welcome to the first episode of Phacilitate Talks!
Episode one of Phacilitate Talks features Lindsey Clarke the European Head of Cell and Gene Therapy at bio-techne, Anthony Davies, CEO of Dark Horse Consulting and Cenk Sumen, CTO of Stemson Therapeutics.

Join us to hear how their teams have adjusted to remote work, their perspective on how Covid-19 has impacted clinical trials and what we do as global community to better prepare for the next pandemic.



In this episode, I refer to a webinar with Kings College, Sexton Biotechnologies and BioBridge Global, which is available on-demand here.


You can also subscribe wherever you get your podcasts:
Apple Podcasts
Stitcher
Spotify
Google Podcasts
Podbean


If you’re not already, don’t forget to sign-up as a Phacilitate member, it’s FREE! Every fortnight you’ll get the latest market intelligence, new ideas and exclusive event offers straight to your inbox. Join a community with the same goal; to help advance a new standard in healthcare.



Back to all episodes >>